Revive Therapeutics Ltd., a life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is proceeding with a phase III clinical trial of Bucillamine in patients with mild-moderate COVID-19 following FDA approval. Revive expects trials to take place in up to 10 clinical trial sites across the U.S.; patient screening will begin in Q3. Yourway is headquartered Allentown, Pennsylvania – with a reliable transportation network, we are able to make deliveries across the country (and around the world) within hours, not days.